SMTL ID : 3dbs.1

Structure of PI3K gamma in complex with GDC0941

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x GD9: 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-yl-thieno[3,2-d]pyrimidine(Non-covalent)

GD9.1: 16 residues within 4Å: Chain A: K.660, M.662, A.663, I.689, K.691, D.694, D.699, Y.725, I.737, E.738, I.739, V.740, T.745, M.811, I.821, D.822 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.821 Hydrogen bonds: A:K.660, A:A.663, A:D.699, A:D.699, A:Y.725, A:V.740, A:D.822, A:D.822

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Folkes, A.J. et al., The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. J.Med.Chem. (2008)

Release Date

2008-06-17

Peptides

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Related Entries With Identical Sequence